X-84361554-T-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 1P and 4B. PP3BS2
The NM_001177479.2(HDX):āc.1364A>Gā(p.Asp455Gly) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000416 in 1,200,935 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 3 hemizygotes in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.0000089 ( 0 hom., 0 hem., cov: 23)
Exomes š: 0.0000037 ( 0 hom. 3 hem. )
Consequence
HDX
NM_001177479.2 missense
NM_001177479.2 missense
Scores
7
7
3
Clinical Significance
Conservation
PhyloP100: 7.84
Genes affected
HDX (HGNC:26411): (highly divergent homeobox) Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be located in nucleus. Predicted to be part of chromatin. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -3 ACMG points.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.764
BS2
High Hemizygotes in GnomAdExome4 at 3 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HDX | NM_001177479.2 | c.1364A>G | p.Asp455Gly | missense_variant | 6/11 | ENST00000373177.3 | NP_001170950.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HDX | ENST00000373177.3 | c.1364A>G | p.Asp455Gly | missense_variant | 6/11 | 1 | NM_001177479.2 | ENSP00000362272 | P1 | |
HDX | ENST00000297977.9 | c.1364A>G | p.Asp455Gly | missense_variant | 5/10 | 1 | ENSP00000297977 | P1 | ||
HDX | ENST00000506585.6 | c.1190A>G | p.Asp397Gly | missense_variant | 5/10 | 2 | ENSP00000423670 |
Frequencies
GnomAD3 genomes AF: 0.00000893 AC: 1AN: 111988Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34150
GnomAD3 genomes
AF:
AC:
1
AN:
111988
Hom.:
Cov.:
23
AF XY:
AC XY:
0
AN XY:
34150
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000336 AC: 6AN: 178468Hom.: 0 AF XY: 0.0000632 AC XY: 4AN XY: 63288
GnomAD3 exomes
AF:
AC:
6
AN:
178468
Hom.:
AF XY:
AC XY:
4
AN XY:
63288
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000367 AC: 4AN: 1088947Hom.: 0 Cov.: 26 AF XY: 0.00000846 AC XY: 3AN XY: 354687
GnomAD4 exome
AF:
AC:
4
AN:
1088947
Hom.:
Cov.:
26
AF XY:
AC XY:
3
AN XY:
354687
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000893 AC: 1AN: 111988Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34150
GnomAD4 genome
AF:
AC:
1
AN:
111988
Hom.:
Cov.:
23
AF XY:
AC XY:
0
AN XY:
34150
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
4
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 18, 2023 | The c.1364A>G (p.D455G) alteration is located in exon 6 (coding exon 4) of the HDX gene. This alteration results from a A to G substitution at nucleotide position 1364, causing the aspartic acid (D) at amino acid position 455 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Uncertain
T
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Pathogenic
D;.;D
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
.;D;D
M_CAP
Uncertain
D
MetaRNN
Pathogenic
D;D;D
MetaSVM
Benign
T
MutationAssessor
Benign
L;.;L
MutationTaster
Benign
D;D;D
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D;.;.
REVEL
Uncertain
Sift
Uncertain
D;.;.
Sift4G
Pathogenic
D;D;D
Polyphen
D;.;D
Vest4
MutPred
Gain of MoRF binding (P = 0.0469);.;Gain of MoRF binding (P = 0.0469);
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at